FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.16  |  FHIR Version n/a  User: [n/a]

Resource ValueSet/FHIR Server from package us.nlm.vsac#0.22.0 (78 ms)

Package us.nlm.vsac
Type ValueSet
Id Id
FHIR Version R4
Source http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.475/expansion
Url http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.475
Version 20250208
Status active
Date 2025-02-08T01:04:21-05:00
Name OGTT_LOINC
Title OGTT_LOINC
Experimental False
Realm us
Authority hl7
Description b.well created value set by Sr. Clinical Business Analyst for OGTT - Oral glucose tolerance tests.
Purpose (Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute OGTT for inclusion and utilization in patients/users connected heath.),(Data Element Scope: OGTT for b.well.),(Inclusion Criteria: OGTT Codes that constitute the Clinical Grouping Event for b.well.),(Exclusion Criteria: N/A)

Resources that use this resource

ValueSet
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.476 OGTT_Grouping

Resources that this resource uses

CodeSystem
http://loinc.org LOINC Code System
http://loinc.org LOINC codes used in this IG
http://loinc.org Logical Observation Identifiers, Names and Codes (LOINC)

Source

{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1235.475",
  "meta" : {
    "versionId" : "7",
    "lastUpdated" : "2025-02-08T01:04:21.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "B.well Connected Health Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2025-02-08"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2025-02-08"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.475",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1235.475"
    }
  ],
  "version" : "20250208",
  "name" : "OGTT_LOINC",
  "title" : "OGTT_LOINC",
  "status" : "active",
  "date" : "2025-02-08T01:04:21-05:00",
  "publisher" : "B.well Connected Health Steward",
  "description" : "b.well created value set by Sr. Clinical Business Analyst for OGTT - Oral glucose tolerance tests.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute OGTT for inclusion and utilization in patients/users connected heath.),(Data Element Scope: OGTT for b.well.),(Inclusion Criteria: OGTT Codes that constitute the Clinical Grouping Event for b.well.),(Exclusion Criteria: N/A)",
  "compose" : {
    "include" : [
      {
        "system" : "http://loinc.org",
        "concept" : [
          {
            "code" : "1496-9",
            "display" : "Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO"
          },
          {
            "code" : "1507-3",
            "display" : "Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO"
          },
          {
            "code" : "1518-0",
            "display" : "Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO"
          },
          {
            "code" : "1533-9",
            "display" : "Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO"
          },
          {
            "code" : "1539-6",
            "display" : "Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO"
          },
          {
            "code" : "21004-7",
            "display" : "Glucose tolerance [Interpretation] in Serum or Plasma"
          },
          {
            "code" : "49688-5",
            "display" : "Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO"
          },
          {
            "code" : "50667-5",
            "display" : "Glucose tolerance [Interpretation] in Serum or Plasma Narrative"
          },
          {
            "code" : "62856-0",
            "display" : "PhenX - oral glucose tolerance test protocol 141001"
          },
          {
            "code" : "6749-6",
            "display" : "Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO"
          },
          {
            "code" : "LA33717-2",
            "display" : "Impaired glucose tolerance"
          },
          {
            "code" : "LP112419-9",
            "display" : "PhenX - oral glucose tolerance test protocol 141001"
          },
          {
            "code" : "LP65536-2",
            "display" : "Glucose tolerance 3H panel"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:269950cf-f61f-483a-b063-e119c85eac74",
    "timestamp" : "2025-05-11T06:39:15-04:00",
    "total" : 13,
    "contains" : [
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "1496-9",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "1507-3",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "1518-0",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "1533-9",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "1539-6",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "21004-7",
        "display" : "Glucose tolerance [Interpretation] in Serum or Plasma"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "49688-5",
        "display" : "Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "50667-5",
        "display" : "Glucose tolerance [Interpretation] in Serum or Plasma Narrative"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "62856-0",
        "display" : "PhenX - oral glucose tolerance test protocol 141001"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "6749-6",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "LA33717-2",
        "display" : "Impaired glucose tolerance"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "LP112419-9",
        "display" : "PhenX - oral glucose tolerance test protocol 141001"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "LP65536-2",
        "display" : "Glucose tolerance 3H panel"
      }
    ]
  },
  "text" : {
  }
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.